Intersect ENT Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 hits record high as rate-hike worries ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Intersect ENT (XENT) Misses Q1 EPS by 9c, Revenues Beat; Raises FY21 Revenues Outlook
May 10, 2021 7:11 AM EDTIntersect ENT (NASDAQ: XENT) reported Q1 EPS of ($0.51), $0.09 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $24.3 million versus the consensus estimate of $23.54 million.
First Quarter 2021 Overview
Revenue of $24.3 million in the first quarter of 2021, up 23%, compared to $19.8 million in the first quarter of 2020.Strong quarterly SINUVA revenue of $2.4 million.Global Balloon and Navigation portfolio generated revenue of $1.5 million.Cash, cash equivalents, restricted cash, and short-term investments were $89.0 million as of March 31, 2021.Increases 2021 full-year revenue guidance to... More